SCHEMBL972392

SCHEMBL972392

OBc1ccc(Cl)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20083331 0.92 CYP1A2 (0.48) —
1,4-Dichlorobenzene SCHEMBL3214891 0.79 LMNA (0.67) —
SCHEMBL2063634 0.73 LMNA (0.57) —
SCHEMBL1411717 0.71 — —
1,4-Dichlorobenzene SCHEMBL5191 0.71 — —
1,4-Dichlorobenzene SCHEMBL11243685 0.71 — —
SCHEMBL14140382 0.69 KMT2A (0.42) —
SCHEMBL8042030 0.69 HSD17B10 (0.46) —
SCHEMBL13191460 0.69 — —
SCHEMBL13619374 0.69 TSHR (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257530-B1 PROCESS FOR PREPARING SUBSTITUTED BIPHENYLANILIDES BAYER CROPSCIENCE AG (DE) 2011-10-12 — — EP claimed
US-20110003999-A1 Process for Preparing Substituted Biphenylanilides BAYER CROPSCIENCE AG (DE) 2011-01-06 — — US claimed
EP-2093216-A1 Process for preparing substituted biphenylanilides Bayer CropScience AG (DE) 2009-08-26 — — EP claimed
EP-3762387-B1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-07-12 — — EP disclosed
EP-3679024-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2022-11-02 — — EP disclosed
US-11384048-B2 Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD. (CN) 2022-07-12 — — US disclosed
US-20220168268-A1 SMALL-MOLECULE INHIBITOR OF PD-1/PD-L1, PHARMACEUTICAL COMPOSITION THEREOF WITH PD-L1 ANTIBODY, AND APPLICATION OF SAME GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD. (CN) 2022-06-02 — — US disclosed
EP-3766885-B1 TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS PFIZER (US) 2022-05-25 — — EP disclosed
EP-3954687-A1 PROCESSES AND INTERMEDIATES USEFUL IN THE PREPARATION OF AN APOPTOSIS-INDUCING AGENT AbbVie Ireland Unlimited Company (IE) 2022-02-16 — — EP disclosed
WO-2021238587-A1 MICROMOLECULAR OXATHIAZINE DERIVATIVE AND USE THEREOF 四川大学华西医院 2021-12-02 — — WO disclosed
EP-3915980-A2 ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE Samsung Display Co., Ltd. (KR) 2021-12-01 — — EP disclosed
EP-2119697-A1 Process for preparing substituted biphenylanilides Bayer CropScience AG (DE) 2009-11-18 — — EP disclosed
WO-2009135598-A1 PROCESS FOR PREPARING SUBSTITUTED BIPHENYLANILIDES BAYER CROPSCIENCE AG 2009-11-12 — — WO disclosed
EP-2093216-A1 Process for preparing substituted biphenylanilides Bayer CropScience AG (DE) 2009-08-26 — — EP disclosed
EP-1833799-B1 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT-2a SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2008-09-10 — — EP disclosed
WO-2008079903-A1 PYRROLO [2, 3-B] PYRIDINE DERIVATIVES AS KINASE MODULATORS PLEXXIKON, INC. (US) 2008-07-03 — — WO disclosed
CN-1972695-A Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones ANACOR PHARMACEUTICALS INC (US) 2007-05-30 — — CN disclosed
CN-1738802-A Antibiotics containing boronic acid complexes and methods of use ANACOR PHARMACEUTICALS INC (US) 2006-02-22 — — CN disclosed
EP-1140947-A1 METHOD FOR PRODUCING MONO-ORGANOBORANES OR DI-ORGANOBORANES Basell Polyolefine GmbH (DE) 2001-10-10 — — EP disclosed
WO-2000037476-A1 METHOD FOR PRODUCING MONO-ORGANOBORANES OR DI-ORGANOBORANES BASELL POLYOLEFINE GMBH (DE) 2000-06-29 — — WO disclosed
Send feedback